Publications by authors named "Matthias Johannes John"

The hepatitis B virus (HBV) has been described as stealth virus subverting immune responses initially upon infection. Impaired toll-like receptor signaling by the HBV surface antigen (HBsAg) attenuates immune responses to facilitate chronic infection. This implies that HBV replication may trigger host innate immune responses in the absence of HBsAg.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Matthias Johannes John"

  • - Matthias Johannes John's research primarily focuses on the interaction between hepatitis B virus (HBV) and the host immune system, particularly how HBV evades immune detection and response mechanisms.
  • - His 2016 study published in "Sci Rep" reveals that HBV genome replication activates toll-like receptor 3 (TLR3)-dependent interferon responses even when the hepatitis B surface antigen (HBsAg) is absent, suggesting a complex role of HBV in modulating immune responses.
  • - The findings highlight the potential for targeting TLR3 pathways as a therapeutic approach to bolstering immune responses against HBV, which may lead to improved outcomes in chronic HBV infections.